Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 5.94% is 43% above its 5-year average of 4.17%, near the high end of its 5-year range (1.72%–5.94%).
As of the fiscal period ended Tuesday, June 30, 2026. 4.25% above its 12-month average of 5.70%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 5.94%.
RETURN ON EQUITY (ROE)
5.94%
RETURN ON EQUITY (ROE) AVG TTM
5.70%
RETURN ON EQUITY (ROE) AVG 3Y
5.42%
RETURN ON EQUITY (ROE) AVG 5Y
4.17%
RETURN ON EQUITY (ROE) AVG 10Y
3.83%
RETURN ON EQUITY (ROE) AVG 15Y
4.38%
RETURN ON EQUITY (ROE) AVG 20Y
5.82%
CURRENT VS TTM AVG
+4.25%
CURRENT VS 3Y AVG
+9.65%
CURRENT VS 5Y AVG
+42.53%
CURRENT VS 10Y AVG
+55.25%
CURRENT VS 15Y AVG
+35.85%
CURRENT VS 20Y AVG
+2.16%
SECTOR MEDIAN · HEALTHCARE
-38.55%
median of 491 covered companies
CURRENT VS SECTOR MEDIAN
+115.42%
vs the sector median at left
HealthStream, Inc.
Market Cap
$913.56M
Return on Equity (ROE)
5.94%
TTM Avg
5.70%
3Y Avg
5.42%
5Y Avg
4.17%
Market Cap
$901.56M
Return on Equity (ROE)
23.86%
TTM Avg
-5.16%
3Y Avg
-37.28%
5Y Avg
-22.23%
Market Cap
$935.68M
Return on Equity (ROE)
-612.78%
TTM Avg
-101.05%
3Y Avg
-68.21%
5Y Avg
-52.21%
Market Cap
$937.09M
Return on Equity (ROE)
-51.43%
TTM Avg
-27.77%
3Y Avg
3.43%
5Y Avg
3.43%
Market Cap
$888.92M
Return on Equity (ROE)
59.16%
TTM Avg
-57.78%
3Y Avg
-58.75%
5Y Avg
-57.09%
Market Cap
$938.73M
Return on Equity (ROE)
-61.58%
TTM Avg
-50.64%
3Y Avg
-52.69%
5Y Avg
41.64%
Market Cap
$875.38M
Return on Equity (ROE)
-24.02%
TTM Avg
-108.12%
3Y Avg
-89.93%
5Y Avg
-68.76%
Market Cap
$854.51M
Return on Equity (ROE)
-33.06%
TTM Avg
-24.59%
3Y Avg
-41.17%
5Y Avg
-18.72%
Market Cap
$852.44M
Return on Equity (ROE)
-28.46%
TTM Avg
-48.75%
3Y Avg
-33.66%
5Y Avg
-33.66%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HealthStream, Inc. (HSTM) | $913.56M | 5.94% | 5.70% | 5.42% | 4.17% |
| Bioventus Inc. (BVS)vs › | $901.56M | 23.86% | -5.16% | -37.28% | -22.23% |
| Kura Oncology, Inc. (KURA)vs › | $935.68M | -612.78% | -101.05% | -68.21% | -52.21% |
| CeriBell, Inc. (CBLL)vs › | $937.09M | -51.43% | -27.77% | 3.43% | 3.43% |
| Arbutus Biopharma Corp (ABUS)vs › | $888.92M | 59.16% | -57.78% | -58.75% | -57.09% |
| MoonLake Immunotherapeutics (MLTX)vs › | $938.73M | -61.58% | -50.64% | -52.69% | 41.64% |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $875.38M | -24.02% | -108.12% | -89.93% | -68.76% |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $854.51M | -33.06% | -24.59% | -41.17% | -18.72% |
| Beta Bionics, Inc. (BBNX)vs › | $852.44M | -28.46% | -48.75% | -33.66% | -33.66% |
| Aktis Oncology, Inc. (AKTS)vs › | $975.17M | -15.09% | 46.85% | 62.20% | 62.20% |
ROE
5.9%
ROA
4.1%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 5.94% |
| 2026-03-31 | 5.66% |
| 2025-12-31 | 5.18% |
| 2025-09-30 | 5.93% |
| 2025-06-30 | 5.80% |
| 2025-03-31 | 5.27% |
| 2024-12-31 | 5.57% |
| 2024-09-30 | 5.54% |
| 2024-06-30 | 5.11% |
| 2024-03-31 | 5.17% |
| 2023-12-31 | 4.46% |
| 2023-09-30 | 3.82% |
| 2023-06-30 | 3.78% |
| 2023-03-31 | 3.52% |
| 2022-12-31 | 3.62% |
| 2022-09-30 | 2.80% |
| 2022-06-30 | 2.17% |
| 2022-03-31 | 2.00% |
| 2021-12-31 | 1.72% |
| 2021-09-30 | 2.09% |
| 2021-06-30 | 2.44% |
| 2021-03-31 | 2.76% |
| 2020-12-31 | 4.22% |
| 2020-09-30 | 5.01% |
| 2020-06-30 | 5.28% |
| 2020-03-31 | 5.03% |
| 2019-12-31 | 4.66% |
| 2019-09-30 | 4.46% |
| 2019-06-30 | 4.31% |
| 2019-03-31 | 4.41% |
| 2018-12-31 | 10.10% |
| 2018-09-30 | 10.57% |
| 2018-06-30 | 10.52% |
| 2018-03-31 | 10.54% |
| 2017-12-31 | 3.33% |
| 2017-09-30 | 1.94% |
| 2017-06-30 | 1.50% |
| 2017-03-31 | 1.22% |
| 2016-12-31 | 1.31% |
| 2016-09-30 | 2.05% |
| 2016-06-30 | 2.58% |
| 2016-03-31 | 2.62% |
| 2015-12-31 | 3.08% |
| 2015-09-30 | 3.39% |
| 2015-06-30 | 3.78% |
| 2015-03-31 | 6.53% |
| 2014-12-31 | 6.19% |
| 2014-09-30 | 5.90% |
| 2014-06-30 | 5.32% |
| 2014-03-31 | 5.46% |
| 2013-12-31 | 5.63% |
| 2013-09-30 | 5.92% |
| 2013-06-30 | 5.88% |
| 2013-03-31 | 6.04% |
| 2012-12-31 | 5.78% |
| 2012-09-30 | 5.90% |
| 2012-06-30 | 5.87% |
| 2012-03-31 | 5.55% |
| 2011-12-31 | 5.74% |
| 2011-09-30 | 10.00% |
| 2011-06-30 | 8.77% |
| 2011-03-31 | 8.30% |
| 2010-12-31 | 7.32% |
| 2010-09-30 | 24.01% |
| 2010-06-30 | 24.70% |
| 2010-03-31 | 26.21% |
| 2009-12-31 | 26.96% |
| 2009-09-30 | 12.32% |
| 2009-06-30 | 11.74% |
| 2009-03-31 | 9.70% |
| 2008-12-31 | 7.77% |
| 2008-09-30 | 12.25% |
| 2008-06-30 | 12.24% |
| 2008-03-31 | 11.42% |
| 2007-12-31 | 11.44% |
| 2007-09-30 | 6.99% |
| 2007-06-30 | 6.38% |
| 2007-03-31 | 6.13% |
| 2006-12-31 | 8.44% |
| 2006-09-30 | 9.20% |
| 2006-06-30 | 9.69% |
| 2006-03-31 | 9.11% |
| 2005-12-31 | 7.41% |
| 2005-09-30 | 3.24% |
| 2005-06-30 | 0.28% |
| 2005-03-31 | -2.09% |
| 2004-12-31 | -4.82% |
| 2004-09-30 | -7.13% |
| 2004-06-30 | -9.12% |
| 2004-03-31 | -11.17% |
| 2003-12-31 | -15.13% |
| 2003-09-30 | -24.29% |
| 2003-06-30 | -31.11% |
